arrow
Z

Zhan Wang

chinese academy of medical sciences and peking union medical college
H指数:25
被引数:2,071

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mycobacterium tuberculosis transmission in China during the COVID-19 pandemic period (2020–2021) compared with the pre-pandemic period (2017–2019)

结核分枝杆菌(Mycobacterium tuberculosis)在中国的COVID-19疫情期间(2020–2021年)传播情况与疫情前时期(2017–2019年)的比较

2025-11-060
OAAI
Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial

安罗替尼联合信迪利单抗作为晚期结直肠癌患者的一线治疗(APICAL-CRC):一项开放标签、单臂、II期试验

2025-09-160
OAAI
Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trial

信迪利单抗联合安罗替尼与序贯化疗治疗晚期三阴性乳腺癌(SPACE)的疗效与安全性:一项单臂、多中心II期研究的初步结果

2024-09-010
PRE
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway)
2023-02-233
OAAI